Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, November 01, 2014
Technology Networks
 
Register | Sign in
Home Page
  News
Return

BioProcessing Solutions Alliance Wins Million Veteran Program Genotyping Contract

Published: Friday, November 08, 2013
Last Updated: Friday, November 08, 2013
Bookmark and Share
The U.S. Department of Veterans Affairs awarded a five-year contract for genotyping to the BioProcessing Solutions Alliance.


For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here


Scientific News
Identifying the Source of Stem Cells
Researchers discover that Sox2 gene could determine the source of stem cells in mammals.
Scientists Generate First Human Stomach Tissue in Lab with Stem Cells
Unprecedented tool for researching the development and diseases of an organ central to several public health crises.
UCL Research Helps Paralyzed Man to Recover Function
UCL scientists develop a pioneering cell transplantation treatment.
Keeping Embryonic Stem Cells in Suspended Animation
Research reveals new strategy to control cellular identity and fate.
Lab-developed Intestinal Organoids form Mature Human Tissue in Mice
Study produces unprecedented model to study intestinal diseases.
Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of ALL Patients Studied
University of Pennsylvania and Children's Hospital of Philadelphia studies reveal unprecedented results with investigational therapy made from patients' own immune cells.
Jump-starting the Creation of New Blood Vessels
A technique to jump-start the body's systems for creating blood vessels for the treatment of peripheral artery disease.
From Stem Cells to Billions of Human Insulin-producing Cells
Giant step toward new diabetes treatment.
Adaptimmune Announces Interim Results from Pilot Trial of NY-ESO T Cells
Study reports encouraging response rate and safety profile.
Positive Safety Results for Macular Degeneration Treatment
Phase 1/2 clinical trials of RPE cells for the treatment of dry age-related macular degeneration and Stargardt’s macular degeneration show positive long term safety results and signs of visual improvement.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv